Company / Working Capital
BioCardia, Inc. Working Capital History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$11.0M
FY2017
5-year range
$11.0M / $20.5M
FY2016-FY2017
Trend
-46.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$11M in FY2017.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, working capital decreased 46.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $11.0M | -46.4% |
| FY2016 | $20.5M | - |
| FY2011 | - | - |
As of FY2017 · SEC Form 10-K · Last checked Jun 21, 2026